Biondo Investment Advisors, LLC Amgen Inc Transaction History

Biondo Investment Advisors, LLC

$724 Million
Q3 2024

A detailed history of Biondo Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Biondo Investment Advisors, LLC holds 32,582 shares of AMGN stock, worth $9.12 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

32,582

Previous 32,255 1.01%

Holding current value

$9.12 Million

Previous $10.1 Million 4.17%

% of portfolio

1.45%

Previous 1.5%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $101,167 - $110,323	327 Added 1.01%	32,582 $10.5 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $239,628 - $291,210	912 Added 2.91%	32,255 $10.1 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $57,807 - $69,780	215 Added 0.69%	31,343 $8.91 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $23,268 - $26,249	-91 Reduced 0.29%	31,128 $8.97 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $287,743 - $357,241	1,316 Added 4.4%	31,219 $8.39 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $418,897 - $495,338	-1,955 Reduced 6.14%	29,903 $6.64 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $652,533 - $795,328	2,890 Added 9.98%	31,858 $7.7 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $99,857 - $126,880	-436 Reduced 1.48%	28,968 $7.61 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $96,966 - $109,360	432 Added 1.49%	29,404 $6.68 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $290,694 - $323,492	1,260 Added 4.55%	28,972 $7.1 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $354,121 - $391,750	1,615 Added 6.19%	27,712 $6.75 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $237,661 - $271,982	1,195 Added 4.8%	26,097 $5.92 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $182,552 - $213,882	860 Added 3.58%	24,902 $5.34 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $258,105 - $286,349	1,105 Added 4.82%	24,042 $5.9 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $145,572 - $169,641	656 Added 2.94%	22,937 $5.75 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $1,081 - $1,288	5 Added 0.02%	22,281 $5.16 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $131,169 - $145,871	559 Added 2.57%	22,276 $5.7 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $3.19 Million - $3.92 Million	16,150 Added 290.1%	21,717 $5.13 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $6,742 - $8,942	-37 Reduced 0.66%	5,567 $1.14 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $946 - $1,216	-5 Reduced 0.09%	5,604 $1.36 Million
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $4,178 - $5,006	24 Added 0.43%	5,609 $1.09 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $833 - $977	-5 Reduced 0.09%	5,585 $1.04 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $3,617 - $4,077	-20 Reduced 0.36%	5,590 $1.07 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $8,028 - $9,371	-45 Reduced 0.8%	5,610 $1.1 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $26,867 - $30,289	-145 Reduced 2.5%	5,655 $1.18 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $46,417 - $51,862	-275 Reduced 4.53%	5,800 $1.02 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $1.02 Million - $1.16 Million	6,075	6,075 $1.14 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.

Account

Biondo Investment Advisors, LLC Amgen Inc Transaction History